Sopharma Trading AD (BUL:SFT)

Sopharma Trading AD Revenue

Sopharma Trading AD had revenue of 319.19M EUR in the quarter ending June 30, 2026, with 9.92% growth. This brings the company's total for the last twelve months to 1.25B, up 13.12% year-over-year. In the year 2025, Sopharma Trading AD had annual revenue of 1.17B with 17.32% growth. That makes Sopharma Trading AD the 6,214th largest company in the world by revenue and 3rd in Bulgaria.

• Revenue (ttm): 1.25B
• Revenue Growth: +13.12%
• P/S Ratio: 0.09
• Revenue / Employee: 333.94K
• Employees: 3,750
• Market Cap: 117.22M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Medicinal and Medical Products 1.15B 98.6%
• Medical Equipment 15.98M 1.4%

By Geography

Chart

• Bulgaria 838.21M 71.9%
• Europe 328.20M 28.1%
• Other Countries 105.38K 0.0%

Fiscal year ended Dec 31, 2025 See the full Sopharma Trading AD breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.17B	173.22M	17.32%
Dec 31, 2024	1.00B	142.08M	16.56%
Dec 31, 2023	858.14M	100.19M	13.22%
Dec 31, 2022	757.95M	74.87M	10.96%
Dec 31, 2021	683.08M	92.06M	15.58%

Data Source: S&P Global Market Intelligence Last updated: Aug 26, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error